Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Serum Free Light Chains
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
When a Monoclonal Gammopathy Is Not Multiple Myeloma | American Society of Clinical Oncology Educational Book
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
TECHNICALREVIEW
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library
The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid - Franz F Konen, Philipp Schwenkenbecher, Ulrich Wurster, Konstantin F Jendretzky, Nora Möhn, Stefan Gingele, Kurt-Wolfram Sühs, Malte
Manni Mohyuddin on Twitter: "130!!!! So thats how high the kappa light goes! And hence,an adjusted kappa/lambda ratio from "0.26 to 1.65" to "0.37 to 3.1" has been suggested to better pick
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
FLC Why choose the Sebia Free Light Chain (FLC) assay?
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS | PLOS ONE